Close

Innerpage

Press Releases

May 17, 2022

Meridian Bioscience Launches Lyo-Ready™ Saliva-Specific Isothermal Amplification Master Mixes for Direct Detection of DNA & RNA in Point of Care Diagnostic Assays

read more
May 06, 2022

MERIDIAN BIOSCIENCE REPORTS RECORD SECOND QUARTER FISCAL 2022 OPERATING RESULTS

read more
May 02, 2022

Meridian Acquires EUPROTEIN to Further Expand Recombinant Protein Capabilities

read more
Apr 07, 2022

Meridian Bioscience Announces Preliminary Net Revenues Results for Fiscal 2022 Second Quarter

read more
Mar 29, 2022

Meridian Bioscience Launches Lyo-Ready™ qPCR Inhibitor Tolerant Blood-Specific Master Mixes for DNA & RNA Direct Detection

read more
Feb 21, 2022

Meridian Bioscience Names Andy Kitzmiller as Chief Financial Officer

read more
Feb 16, 2022

Magellan Diagnostics Resumes Distribution of LeadCare® II Test Kits

read more
Feb 04, 2022

MERIDIAN BIOSCIENCE REPORTS SECOND BEST QUARTER IN COMPANY HISTORY

read more
Jan 31, 2022

Meridian Bioscience Receives Additional NIH Award to Support the Rapid Development of the Revogene® Molecular Viral Respiratory Testing Panel

read more
Jan 28, 2022

Meridian Bioscience Launches Lyo-Ready™ qPCR Saliva-Specific Master Mixes for DNA & RNA Direct Detection

read more
Jan 27, 2022

Meridian Bioscience Elects John C. McIlwraith New Chairman of the Board

read more
Jan 10, 2022

Meridian Bioscience to Hold First Quarter 2022 Financial Results Conference Call on February 4, 2022

read more
Jan 05, 2022

Meridian Bioscience Receives FDA-Clearance for the Curian® Campy Assay

read more
Jan 04, 2022

Meridian Bioscience to Participate in the 2022 H. C. Wainwright Bioconnect Virtual Conference

read more
Dec 02, 2021

Meridian Bioscience Announces Retirement of CFO Bryan Baldasare

read more
Nov 24, 2021

Meridian Bioscience Announces Retirement of Chairman David Phillips

read more
Nov 18, 2021

Meridian Bioscience Participates in Piper Sandler 33rd Annual Virtual Healthcare Conference

read more
Nov 17, 2021

Meridian Launches Two New Air-Dryable™ Mixes for Isothermal Amplification, Powering Shortest Time-to-results in Point-of-care Testing

read more
Nov 12, 2021

Meridian Bioscience Reports Strong Fourth Quarter And Record Full-Year Fiscal 2021 Operating Results And Provides Fiscal 2022 Guidance

read more
Nov 10, 2021

Meridian Bioscience Receives FDA Emergency Use Authorization for Revogene® SARS-CoV-2 Molecular Assay

read more